Study of XB010 in Subjects With Solid Tumors

Recruiting

Phase 1

Study of XB010 in Subjects With Solid Tumors

Sponsor:

Exelixis

Code:

NCT06545331

Conditions

Locally Advanced or Metastatic Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

XB010

Pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information